Systemic Prevention and Management for Perioperative Hypothermia and Its Effect on Patients Outcome

March 14, 2019 updated by: Jie YI, Peking Union Medical College Hospital

Establishment of Systemic Prevention and Management for Perioperative Hypothermia and Its Effect on Patients Outcome-a Prospective Multiple Centers Randomized Controlled Study

This is a randomized, single-blinded, multi-center study clinical trial to determine both clinical and health outcomes of stratified warm strategy to prevent intraoperative hypothermia. Participants enrolled into this trial will be from elective major surgery population in PUMC Hospital, Beijing Hospital and Xuanwu Hospital. investigators plan to enroll approximately 800 participants. Hypothermia risk will be evaluated through PREDICTOR model in all participants. According to hypothermia risk level, these participants will be stratefied into high, moderate and low risk group. Participants in each group will be randomly categorize into warm group and control group. Active warm and fluid warm strategy, prewarm and fluid warm strategy and only prewarm strategy are used for high risk, moderate risk and low risk patients seperately. For controll group traditional passive warm was used.

Study Overview

Study Type

Interventional

Enrollment (Anticipated)

800

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

  • Name: Jie Yi, doctor
  • Phone Number: 13701362812
  • Email: neyil@pumch.cn

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

Age≥18 Core temperature preoperation ≥36.0 ℃ and ≤37.5℃ ASA I-III Informed consent

Exclusion Criteria:

  • emergency operation
  • uncontrolled diebete mellitus with insulin treatment (preoperative blood glucose>250mg/dL)
  • hyperthyroidism and hypothyroidism
  • Raynaud's disease
  • patients with hematopathy and immune disease
  • anticoagulant and non-steroid anti-inflammatory drug intake with 14 days before operation
  • infectious fever within 4 weeks before operation
  • laboratory abnomality as follow
  • Hemoglobin≤10.0g/L
  • Platelet≤100,000/ml
  • White blood cell<3000/dl or>14,000/dl
  • Fibrinogen<200mg/dL
  • Thrombin time>40 second
  • International normalized ratio<70%

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Sham Comparator: control group
Cotton Blanket Warming (CBW) starts 30 min preoperatively and then continues throughout the entire operation.
cotton blanket warming through operation
Experimental: warm group

Warm according to different hypothermia risk for low risk ---Forced-air warming(FAW) starts at least 30 min preoperatively and then Cotton Blanket Warming (CBW) continues throughout the entire operation.

moderate risk---Forced-air warming(FAW) starts at least 30 min preoperatively and then Cotton Blanket Warming (CBW) and fluid warming continues throughout the entire operation.

high risk ----Forced-air warming(FAW) starts at least 30 min preoperatively, FAW and fluid warming continues throughout the entire operation.

Bair HuggerTM Forced-air Warming System to 30min pre- and entire operation warming, combined fluid warming
30 min prewarming The Bair HuggerTM Forced-air Warming System cotton blanket warming and fluid warming through operation
30 min prewarming The Bair HuggerTM Forced-air Warming System and cotton blanket warming through operation

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Incidence of intraoperative hypothermia
Time Frame: During operation
Core temperature<36℃
During operation

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
The amount of Intraoperative blood loss/blood transfusion
Time Frame: During operation
During operation
Length of stay in PACU
Time Frame: Postoperative during in postanaesthesia care unit, up to 24 hours after surgery
Postoperative during in postanaesthesia care unit, up to 24 hours after surgery
The incidence of Surgical site infection
Time Frame: WIthin 30 days postoperative
WIthin 30 days postoperative
Lenght of Stay in hospital
Time Frame: impatient period, up to 6 month after surgery
impatient period, up to 6 month after surgery
Lenght of Stay in ICU
Time Frame: impatient period, up to 6 month after surgery
impatient period, up to 6 month after surgery
Incidence of Adverse cardiovascular events
Time Frame: WIthin 6 month post operation
WIthin 6 month post operation
Incidence of shiver
Time Frame: during in postanaesthesia care unit, up to 24 hours after surgery
during in postanaesthesia care unit, up to 24 hours after surgery
Mini-Mental State Examination (MMSE),
Time Frame: One day preoperation and 1 , 7,30 days postoperation
It's a scare to evaluate cognitive function. Total score is 30 . Higher values represent a better cognitive function.
One day preoperation and 1 , 7,30 days postoperation
digit symbol substitution test
Time Frame: One day preoperation and 1 , 7,30 days postoperation
The digit symbol substitution test is an evaluation tool used to assess cognitive functioning. It initially was part of the Wechsler Adult Intelligence Test (WAIS), a well-known test that measures an individual's attention. lower digit symbol test scores were correlated with a higher risk of developing dementia in both the five and 10 year groups.Higher values represent a better cognitive function.
One day preoperation and 1 , 7,30 days postoperation
Auditory Verbal Learning Test,
Time Frame: One day preoperation and 1 , 7,30 days postoperation
a memory test that involves learning verbal material, usually single words presented in a list, that is continually presented over repeated trials. Higher values represent a better memory functions.
One day preoperation and 1 , 7,30 days postoperation
Color Word Stroop Test
Time Frame: One day preoperation and 1 , 7,30 days postoperation
The Stroop Colour and Word Test (SCWT) is a neuropsychological test extensively used to assess the ability to inhibit cognitive interference that occurs when the processing of a specific stimulus feature impedes the simultaneous processing of a second stimulus attribute, well-known as the Stroop Effect. Higher values represent a better ability to inhibit cognitive interference.
One day preoperation and 1 , 7,30 days postoperation
digit span test.
Time Frame: One day preoperation and 1 , 7,30 days postoperation
a memory test that involves remember a series of numbers test short time memory Higher values represent a better memory functions.
One day preoperation and 1 , 7,30 days postoperation
postoperative cognitive dysfunction incidence
Time Frame: One day preoperation and 1 , 7,30 days postoperation
  • Z score=(postoperative score-preoperative core)/SD of non-surgical group
  • Two or more than two item in cognitive examination Z score<-1.96
  • Z score=(postoperative score-preoperative core)/SD of non-surgical group Two or more than two item in cognitive examination Z score<-1.96
One day preoperation and 1 , 7,30 days postoperation

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Chair: Yuguang Huang, doctor, Peking Union Medcial College Hospital

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Anticipated)

April 1, 2019

Primary Completion (Anticipated)

March 31, 2021

Study Completion (Anticipated)

August 31, 2021

Study Registration Dates

First Submitted

March 13, 2019

First Submitted That Met QC Criteria

March 14, 2019

First Posted (Actual)

March 18, 2019

Study Record Updates

Last Update Posted (Actual)

March 18, 2019

Last Update Submitted That Met QC Criteria

March 14, 2019

Last Verified

March 1, 2019

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

  • Hypothermia2018

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

IPD Plan Description

There is not a plan to make IPD available.

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Hypothermia; Anesthesia

Clinical Trials on passive warming

3
Subscribe